tiprankstipranks
LumiraDx receives Nasdaq delisting determination, plans to appeal
PremiumThe FlyLumiraDx receives Nasdaq delisting determination, plans to appeal
1y ago
LumiraDx reports Q2 adjusted EPS (16c), consensus (14c)
Premium
The Fly
LumiraDx reports Q2 adjusted EPS (16c), consensus (14c)
1y ago
LMDX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LMDX Upcoming Earnings Report: What to Expect?
1y ago
LumiraDx receives noncompliance notification from Nasdaq
PremiumThe FlyLumiraDx receives noncompliance notification from Nasdaq
2y ago
LumiraDx price target lowered to $1.50 from $2 at Raymond James
Premium
The Fly
LumiraDx price target lowered to $1.50 from $2 at Raymond James
2y ago
LumiraDx Plans Massive Cost-Cutting Measures
Premium
Market News
LumiraDx Plans Massive Cost-Cutting Measures
2y ago
LumiraDx receives noncompliance notification from Nasdaq
PremiumThe FlyLumiraDx receives noncompliance notification from Nasdaq
2y ago
LumiraDx initiated with a Neutral at Goldman Sachs
Premium
The Fly
LumiraDx initiated with a Neutral at Goldman Sachs
2y ago
LumiraDx continues commercial expansion of HbA1c test
Premium
The Fly
LumiraDx continues commercial expansion of HbA1c test
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100